These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1704122)

  • 1. Endogenous interferon (IFN) in patients with acute hepatitis B.
    Boron-Kaczmarska A; Zachoval R; Zachoval V; Deinhardt F
    Acta Med Hung; 1990; 47(1-2):77-80. PubMed ID: 1704122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human interferon on vesicular stomatitis virus released from bovine embryonic kidney cells.
    Harrell SA; Maheshwari RK; Mohanty SB; Friedman RM
    Am J Vet Res; 1982 Apr; 43(4):565-8. PubMed ID: 6176154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C.
    Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis.
    Kakumu S; Fuji A; Yoshioka K; Tahara H
    Hepatogastroenterology; 1989 Apr; 36(2):97-102. PubMed ID: 2499528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon production in acute virus hepatitis].
    Pirovino M; Aguet M; Huber M; Altorfer J; Schmid M
    Leber Magen Darm; 1984 Nov; 14(6):258-60. PubMed ID: 6083427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and biochemical characterization of vesicular stomatitis virus with low infectivity released from interferon treated cells.
    Maheshwari RK; Friedman RM
    Uttar Pradesh State Dent J; 1980 Jul; 11(3):95-110. PubMed ID: 6159713
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of correlation in the interferon-induced small Mw 2-5A synthetase mRNA levels and sensitivity of two L cell sublines to the antiviral and priming effects of interferon.
    Rosztóczy I; Content J
    Acta Virol; 1990 May; 34(3):288-90. PubMed ID: 1703394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating acid-labile interferon in chronic versus acute, HBV-related liver disease. A marker of immune-mediated hepatocellular damage?
    Biglino A; Cariti G; Gioannini P
    Boll Ist Sieroter Milan; 1985; 64(3):201-6. PubMed ID: 2412572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of oxygen on the antiviral activity of human interferon in cell culture].
    Krivokhatskaia LD; Povolotskiĭ IaL; Spivak NIa
    Antibiotiki; 1980 Jun; 25(6):464-6. PubMed ID: 6156641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the antiviral and antiproliferative activity of human interferon preparations obtained in suspension and stationary cultures of donor leukocytes].
    Timofeev IV; Kuznetsov VP; Mekhedov LN; Nikolaeva TG; Orlova TG
    Antibiotiki; 1981 Sep; 26(9):703-5. PubMed ID: 6170254
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating interferon in human autoimmune diseases.
    Hooks JJ; Moutsopoulos HM; Notkins AL
    Tex Rep Biol Med; 1981-1982; 41():164-8. PubMed ID: 6184802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon level in human normal sera.
    Ghyka G; Savi I
    Med Interne; 1987; 25(1):43-6. PubMed ID: 3035701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer activity in patients with acute viral hepatitis.
    Chemello L; Mondelli M; Bortolotti F; Schiavon E; Pontisso P; Alberti A; Rondanelli EG; Realdi G
    Clin Exp Immunol; 1986 Apr; 64(1):59-64. PubMed ID: 3089650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Presence of circulating interferon in serum of patients with Plasmodium falciparum].
    Rhodes-Feuillette A; Druilhe P; Canivet M; Gentilini M; Périés J
    C R Seances Acad Sci III; 1981 Nov; 293(11):635-7. PubMed ID: 6174189
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of interferon action. Interferon alpha inhibits vesicular stomatitis virus primary transcript accumulation in P1/eIF-2 alpha protein kinase-deficient human fibroblast cells.
    Zhang XT; Samuel CE
    J Biol Regul Homeost Agents; 1987; 1(4):157-65. PubMed ID: 2845723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral and non-antiviral activity of highly purified interferon.
    Stewart WE; DeClercq E; De Somer P; Berg K; Ogburn CA; Paucker K
    Nat New Biol; 1973 Dec; 246(153):141-3. PubMed ID: 4357391
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of endogenous interferon in the high sensitivity of C3H/10T1/2 cells to the antiviral activity of interferon.
    Wybier-Franqui J; Brouty-Boyé D
    J Interferon Res; 1992 May; Spec No():17-22. PubMed ID: 1379282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.
    Wallach D
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-albumin conjugate with conserved biological activity.
    Traub A; Payees B; Reuveny S; Mizrahi A
    J Gen Virol; 1981 Apr; 53(Pt 2):389-92. PubMed ID: 6167669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.